Haraldsted V Y, Nielsen J W, Madsen J V, Hasselstrøm L
Department of Anaesthesia and Intensive Care, Randers Centralsygehus, Denmark.
Br J Anaesth. 1988 Apr;60(5):491-4. doi: 10.1093/bja/60.5.491.
In a double-blind study, 39 patients (ASA groups I-II,) were given either pancuronium or atracurium as an infusion during surgery. The drugs were given as an initial loading dose of 0.064 mg kg-1 or 0.30 mg kg-1, respectively, followed by an infusion, the rate of which was regulated to produce a constant 95% depression of the evoked twitch response throughout surgery. No significant difference in the number of corrections of the infusion rate per hour was found (4.6 v. 4.9). Mean infusion maintenance doses were 35 and 356 micrograms kg-1 h-1, respectively. The inter-individual variability of maintenance doses for the two drugs did not differ, the coefficients of variation being 0.32 and 0.24. On stopping the infusion, the patients given atracurium recovered to a 15% twitch faster than those given pancuronium. In addition neostigmine produced a quicker recovery in this group. Thus atracurium may be a more satisfactory drug for use by infusion.
在一项双盲研究中,39例患者(美国麻醉医师协会分级I-II级)在手术期间接受泮库溴铵或阿曲库铵静脉输注。分别给予初始负荷剂量0.064mg/kg或0.30mg/kg,随后进行输注,输注速率调节为在整个手术过程中使诱发抽搐反应持续抑制95%。每小时输注速率的校正次数未发现显著差异(4.6对4.9)。平均输注维持剂量分别为35和356μg/kg·h-1。两种药物维持剂量的个体间变异性无差异,变异系数分别为0.32和0.24。停止输注时,接受阿曲库铵的患者比接受泮库溴铵的患者恢复至15%抽搐的速度更快。此外,新斯的明在该组中使恢复更快。因此,阿曲库铵可能是一种更适合静脉输注使用的药物。